Baby-hamster kidney (BHK) cells were grown continuously in long-term monolayer culture in the presence of Swainsonine, an inhibitor ofa-mannosidase II, a processing enzyme involved in glycoprotein biosynthesis. The asparagine-linked oligosaccharides (N-glycans) were isolated from Pronase-digested cells by gel filtration, ion-exchange chromatography and affinity chromatography on concanavalin A-Sepharose and lentil lectin-Sepharose. The major N-glycans, analysed by 500 MHz 'H-n.m.r. spectroscopy, were identified as hybrid structures containing five mannose residues and neutral high-mannose N-glycans. The major hybrid species contained a core-substituted fucose cz(l-+6) residue and a NeuNAca(2-*3)Galfl(1-4)GlcNAc terminal sequence; smaller amounts of non-sialylated and non-fucosylated hybrid structures were also detected. Swainsonine-treated cells also produced neutral oligosaccharides containing a single reducing Nacetylglucosamine residue substituted with polymannose sequences. The glycopeptide composition of Swainsonine-treated BHK cells resembles closely that of the ricin-resistant BHK cell mutant, RicR21 [P. A. Gleeson, J. Feeney and R. C. Hughes (1985) Biochemistry 24, 493-503], except the hybrid structures of RicR21 cells contain three, not five, mannose residues. Like RicR21 cells, Swainsonine-treated BHK cells showed a greatly increased resistance to ricin cytotoxicity, but not to modeccin, another galactose-binding lectin. These effects were readily reversed on removal of Swainsonine and growth in normal medium.
INTRODUCTION
Swainsonine, a trihydroxylated indolizidine alkaloid, is a potent inhibitor of a-D-mannosidase activities (Dorling et al., 1980; Tulsiani et al., 1985) . When added to cells in culture, Swainsonine accumulates in lysosomes to produce a deficiency similar to genetic ac-mannosidosis (Cenci di Bello et al., 1983) . Additionally, Swainsonine is known to induce alterations in the assembly of asparagine-linked oligosaccharides (N-glycans) of glycoproteins. The normal conversion of high-mannose Nglycans to complex N-glycans is prevented and, instead, hybrid structures are formed (Elbein et al., 1981 (Elbein et al., , 1982 Tulsiani et al., 1982 Tulsiani et al., , 1985 Arumugham & Tanzer, 1983; Gross et al., 1983) . Formation of hybrid structures is consistent with the inhibition by Swainsonine of a-mannosidase II, a Golgi glycosidase involved in processing of N-glycans during assembly of fully glycosylated glycoproteins (Tulsiani et al., 1982) .
Recent work from our laboratory has shown that hybrid N-glycans are present in minor amounts in the glycoproteins of normal BHK cells (Hughes & Mills, 1985) , although the predominant processing pathways in these cells lead to conventional complex N-glycans.
Several ricin-resistant mutants of BHK cells produce exclusively hybrid N-glycans after processing , the structures of which account satisfactorily (Baenziger & Fiete, 1979) for the inability of ricin to bind to the mutant cell surface and hence the resistance of the cells to the toxin. The relationship between the assembly of hybrid structures, the rounded morphology and the reduced adhesiveness of ricin-resistant BHK cells (Edwards et al., 1976; Pena & Hughes, 1978) is less clear.
In order to relate the altered glycosylation patterns of ricin-resistant BHK cells to these biological properties, we have examined the effects of Swainsonine on normal BHK cells.
EXPERIMENTAL Materials
Chemicals and biochemicals. Bio-Gel P2 (100-200 mesh) and Chelex 100 (100-200 mesh, Na+ form) were from Bio-Rad Laboratories. Con A-Sepharose and lentil lectin-Sepharose were from Pharmacia.
[35S]Methionine (1.34Ci/mmol), D-[2-3H]mannose (13.4 Ci/mmol), L-[5,6-3H]fucose (64 Ci/mmol) and 2-amino-2-deoxy-D-[1-14 C]-glucose hydrochloride (56.8 Ci/mmol) were from Amersham International. Ricin was from Miles Laboratories and modeccin from Pierce. Jack-bean (Canavalia jack-bean a-mannosidase-catalysed hydrolysis of pnitrophenyl ix-mannoside tSigma) was inhibited completely by I um-Swainsonine (0.173 ,tg/m1). Phosphatebuffered saline contained NaCi (B.0 g), KCI (0.29 g), Na'2HP04 (1-19 g), KH2PO (0.29 g), CaC4 (0.19 g) and MgC12 (0.19 g) diluted to 1 litre with water (pH 7.04).
Buffer A contained 10 mM-Tis/HC1, pH 7.5, 0.1 M-NaCl, I mM-Mg(Cl, 1 mm-CaCl,, 1 mm-MnC12, and 0.02% NaN;,. Buffer B contained 50 mM-Tris/HCl, pH 7.5, 10 nm-CaCI2 and 0.02% NaN,.
Cells. BHK fibroblasts (BHK21 C13) were grown at 37 'Cinmonolayer cultures eitheronstandardplasticware or in glass roller bottles (800 cm2 surface area). In the latter cultures the medium was supplemented with 5 mM-Hepes to maintain a correct pH without C02/air gassing. When indicated, the growth medium was supplementedwithSwainonine(2-5 ,ug/ml). Nodifference in growth rate or plating efficiency was noted when Swainsonine-supplemented medium, rather than normal medium, was used, even over 1-2 months of continuous culture. For subculturing, cell monolayers were trypsintreated as described by Meager et al. (1976) , pelleted by centrifugation at 800 g for 5 min, resuspended in complete serum-supplemented medium and added at approx. 1:4 dilution in complete medium for re-growth at 37 'C. Cells used for preparation of glycopeptides were harvested by first rinsing the monolayer cultures with phosphate-buffered saline, and then scraping off the cells with a rubber policeman. The cells were pelleted at 800 g for 10 min and washed several times with phosphatebuffered saline. Metabolic labelling of cells was carried out by growth of the cells at 37 'C in media supplemented as indicated with [3H]fucose (4,Ci/ml), [3H]mannose (20 #uCi/ml) or ['4C]glucosamine (5 1sCi/ml).
Methods
Pronase digestion. In small-scale experiments, cell pellets were suspended in Buffer B (0.5 ml), heated at 100 'C for 5 min and incubated under toluene at 37 'C with Pronase [50 ld; 0.4% (w/v) in Buffer B]. Fresh aliquots (50 ,1 each) ofPronase were added after 24 h and 48 h incubation at 37 'C. The mixtures were again heated as described above after 72 h, centrifuged at 10000 g for 10 min, and portions of the supernatants were analysed. In the large-scale experiments, the cell pellet (approx. 109 cells) was extracted once with 100 ml of chloroform/ methanol (2:1, v/v) at room temperature for 2 h to remove glycolipids. The residue, recovered by centrifugation at 8000 g for 30 min, was treated with chloroform/ methanol a second time and the residue was suspended in Buffer B (60 ml). After heating at 100 'C for 5 min, the solution was incubated at 37 'C with Pronase (30 mg). Additional portions (30 mg) of Pronase were added each day for a total incubation time of4 days. The mixture was then heated at 100 'C for 5 min, cooled and incubated at 37 'C for 1 h with bovine pancreatic DNAase (0.002 mg/ml) to reduce the viscosity. The mixture was again heated at 100°C for 5 min and centrifuged at 8000 g for 30 min. The residue was washed twice with Buffer B and the supernatants were removed and pooled for preparation of glycopeptides.
Purification of glycopeptides. Portions (40 ml) of the supernatant (80 ml) from Pronase digestion were applied to a column (4 cm x 112 cm) of Sephadex G-25, which was washed with water at room temperature. Fractions (6 ml) were collected and aliquots (0.2 ml) were counted for 3H/14C radioactivity. Fractions S1 and S2 (Fig. la  below) were pooled, freeze-dried and dissolved in water (3 ml). Approx. 85-90% of the total radioactivity was recovered. Fractions S1 and S2 were applied separately to a column (1.4 cm x 36 cm) of Con A-Sepharose equilibrated with Buffer A. Fractions (2 ml)were collected by elution, first with Buffer A, then with 10 mM-a-methyl glucoside, and finally with 200 mM-a-methyl mannoside. The major fractions obtained from Con A-Sepharose chromatography of SI (Fig. lb) and S2 (Fig.. lc) represented 65-73% of the radioactivity applied. The pooled fractions were freeze-dried, dissolved in water (2 ml) and desalted by passage through a column (2 cm x 27 cm) of Bio-Gel P2. Peak radioactive fractions 15-23 (each 2 ml) eluted from Bio-Gel P2 with water were again freeze-dried, dissolved in water (2 ml) and separated further by ion-exchange chromatography. A column (1 cm x 20 cm) of DEAE-Sephacel was equilibrated with 50 mm-acetic acid at 2 'C. Glycopeptide samples (2 ml) were applied to the column, which was washed first with water (22 ml), followed by a salt gradient made up by running 0.5 M-NaCl in 50 mM-acetic acid (45 ml) into 50 mM-acetic acid (45 ml). Fractions (1.4 ml) were collected and samples (10-25 ,tl) assayed for 3H/14C radioactivity. Peak fractions were pooled (Figs Id and 1 e), freeze-dried and dissolved in water (2 ml). The recovery of radioactivity was more than 95%. In the final step of purification, fractions obtained from DEAESephacel were applied separately to a column (0.9 cm x 12 cm) of lentil lectin-Sepharose equilibrated at room temperature in Buffer A. Column fractions (1 ml) were collected by elution with Buffer A followed by 200 mm a-methyl glucoside. Aliquots (10-25 1d) were assayed for radioactivity, and peak fractions (Figs. lf-lh) were pooled, freeze-dried and dissolved in water. Each fraction was desalted on Bic-Gel P2 as described above. The recovery ofradioactivity from lentil lectin-Sepharose was greater than 88%.
Analytical chromatography. Glycopeptide fractions (usually 0.05-0.10 ml; 1000-15000 c.p.m. of 3H; 200-1000 c.p.m. of 14C)were applied to columns (approx. 2.5 ml bed volume) of Con A-Sepharose. The columns were washed with Buffer A at room temperature and five 1 ml fractions were collected. The columns were then washed with 10 mM-a-methyl glucoside (9 ml) followed by 500 mM-a-methyl mannoside (9 ml). Column fractions (1 ml) were assayed for radioactivity. Analytical chromatography of glycopeptides on lentil lectin-Sepharose columns (approx. 2.5 ml) was performed similarly, except that the columns were washed first with Buffer A (5 ml) followed by 200 mM-a-methyl glucoside (9 ml).
Lectin cytotoxicity. BHK cells grown at 37 'C for at least 3 days in 75 cm2 plastic flasks in Glasgow-modified minimal essential medium or medium supplemented with Swainsonine (5 jg/ml) were harvested by trypsin treatment and dispensed into 9.6 cm2 dishes containing 1 ml of medium with or without Swainsonine. The cells were grown to near confluence over 1-2 days at 37°C, the growth medium was removed and replaced with either ricin or modeccin (0-20,g/ml) in Glasgow-modified minimal essential medium (1 ml) with or without Swainsonine (5 /ug/ml). After incubation at 37°C for 2-15 h, the medium was replaced with 1 ml of [35S]methionine (5 ,uCi/ml) in methionine-depleted Glasgow-modified minimal essential medium. Labelling was carried out at 37°C for 1 h, after which the monolayers were rinsed four times at 2°C (2 ml each time) with phosphate-buffered saline, followed by 10% (v/v) HCI04/2% (w/v) phosphotungstic acid and finally ethanol. The residues were dissolved in hot (80°C) IMNaOH and samples (0.05-0.2 ml) were assayed for protein (Bradford, 1976) and radioactivity.
Glycosidase digestion. Treatments with endo-fl-Nacetylglucosaminidase H or D (10 munits) were carried out in 100,l of 0.1 M-sodium citrate buffer, pH 5.5, or 0.15 M-sodium phosphate buffer, pH 6.5, respectively, at 37°C for up to 48 h. The reactions were stopped by boiling for 5 min and the products were fractionated on analytical columns of Con A-Sepharose as described above.
T.i.c. of oligosaccharides. Samples Onof cell oligosaccharides (1620 c.p.m. of [14C]glucosamine) and authentic neutral oligosaccharides (Abraham et al., 1983) isolated from the urine of Swainsonine-treated rats or guinea pigs
(1-1Ol ; 1 mg/ml) of known structure Tulsiani & Touster, 1983) N.m.r. spectroscopy. Glycopeptide samples (30-55 nmol) were prepared for spectroscopy and analysed as described previously , except the samples were freeze-dried between each cycle of exchange with 2H20.
Hexosamine analysis. The hexosamine content ofglycopeptides was analysed (Hughes, 1970) after hydrolysis of samples in 4M-HCI at 100°C for 3 h. The hydrolysates were evaporated to dryness before chromatography on a column (1 cm x 20 cm) of Dowex 50 (X8; 200-400 mesh), equilibrated with 0.1 M-pyridine/acetate buffer, pH 2.8. Fractions (2 ml) were collected during elution first with the same buffer (60 ml), followed by 0.133 M-pyridine/acetate buffer, pH 3.85. Total hexosamines were determined by a modified Elson-Morgan reaction (Hughes, 1970) . Reduction of oligosaccharides was carried out with 1% (w/v) NaBH4 in 50 mM-sodium borate buffer, pH 8.9 (75,u) at 37°C for 2 h. Excess reagent was destroyed with 1 M-HCI (100,1).
Other procedures. Liquid-scintillation counting of sample (up to 0.5 ml) radioactivity was carried out with EP (Beckman) scintillant (10 ml). 
RESULTS

Glycopeptide fractionation
The [3H]mannose/[14C]glucosamine-labelled glycopeptide mixture obtained from Swainsonine-treated BHK cells was separated into two major fractions by gel filtration (Fig. 1 a) . Fraction S1 was enriched in 14C radioactivity relative to fraction S2. Affinity chromatography of fraction S1 on Con A-Sepharose produced (Fig. lb) Abbreviations: (i), internal residue; (t), terminal residue; Gn, N-acetylglucosamine; eq., equitorial; ax., axial. Fraction S2 from Sephadex G-25 (Fig. la) gave several peaks when subjected to chromatography on Con A-Sepharose (Fig. Ic) . The major peak, S2-D, representing 72% of total radioactivity, was eluted with 200 mM-methyl a-mannoside and minor peaks (S2-A, S2-B and S2-C) with weak affinity for Con A were eluted with buffer or 10 mM-a-methyl glucoside. Fractions S2-C and S2-D contained only neutral glycopeptides, as shown by DEAE-Sephacel chromatography (Fig. le) , and were eluted unretarded from lentil lectin-Sepharose (results not shown).
Structures of Si glycopeptides
The n.m.r. spectra of the major acidic glycopeptides SI -C and D (Fig. 2) 
N-acetylglucosamine residue of the core sequence, in agreement (Kornfeld et al., 1981) with the separation of these glycopeptides on lentil lectin-Sepharose (Fig. Ig) (Fig. 2) . Assuming approximately equal labelling of N-acetylneuraminic acid and N-acetylglucosamine by growth of cells in [14C] glucosamine, these results are consistent with Si-B being a non-sialylated core fucosylated hybrid structure containing five mannose residues. Glycopeptides SI-E and SI-F are more acidic than the monosialylated hybrid glycopeptides S1-C and S1-D, as shown by DEAE-Sephacel chromatography (Fig. Id) and also contain more glucosamine label (14C/3H ratios: SI-E, 1.61: 1; SI-F, 2.23: 1). Since glycopeptide Si -E was converted into a neutral species by neuraminidase treatment (results not shown), the increased acidity may be explained by additional sialylation. As one possibility, glycopeptide S1-E may represent a branched hybrid structure containing two NeuNAc-Gal-GlcNAc sequences substituted fl(i-÷2) and ,/(1-4) to the z(I-13)-linked mannose unit of the core sequence. Similar branched hybrid structures have been detected in the glycoproteins of ricin-resistant RicR21 cells . Unlike the latter glycopeptides, however, the proposed branched hybrid glycopeptide retains affinity for Con A and hence contains at least three interacting mannose residues. This structural feature is Vol. 233 Fuca(l -÷6) 701 consistent with a branched hybrid composition containing a total of five mannose units.
Glycopeptide SI-A is the fraction of Con A-binding glycopeptides that did not bind to either DEAE-Sephacel or lentil lectin (Fig. If) , identified as a Man6 structure:
Mana(l -+6) minor amounts migrating with Man4GlcNAc and in S2-D, Man3GlcNAc. The 500 MHz 'H-n.m.r. spectra at 70°C showed a complex pattern in the anomeric region in agreement with the presence ofseveral oligomannosidic components as identified by t.l.c. However, the N-acetyl region showed one abundant singlet at 2.056 p.p.m. confirming (Mutsaers et al., 1985) Man,/(l -->4)GlcNAc,6(1
Structure of S2 components
The major components S2-C and S2-D of this fraction consist of neutral compounds that bind to Con A (Fig.   1 c) , but not to lentil lectin, and contain less [14C]-glucosamine label than the glycopeptides of Sephadex G-25 fraction S1 (3H/14C ratios: S2-C, 7.40:1; S2-D, 6.86:1; S1-A, 5.80:1). The glucosamine is present exclusively at the reducing end of the oligosaccharides (Fig. 3) . After reduction of S2-D with NaBH4 followed by acid hydrolysis, all of the 14C radioactivity was eluted from a Dowex-50 column in the position (Hughes, 1970) of glucosaminitol. Analysis of fractions S2-C and S2-D by t.l.c. showed (Fig. 4) that the predominant oligosaccharide migrated with a Man5GlcNAc standard with glycopeptides obtained by Pronase digestion of disrupted cells were analysed by chromatography on Con ASepharose (Fig. 5) . The predominant glycopeptide species labelled in the control cells were present in fractions eluted unretarded from the column (650% of total) or eluted with 10 mM-a-methyl glucoside (29% of total). Previous work ) has established these structures as respectively, tri-and tetra-antennary complex N-glycans and bi-antennary complex N-glycans. In contrast, about two-thirds of the radioactive material obtained from Swainsonine-treated cells was bound tightly to Con A-Sepharose and was eluted with 500 mM-ac-methyl mannoside. Approx. 90%o column (2 ml) and eluted with 200 mM-a-methyl glucoside in agreement with the structures deduced by n.m.r. spectroscopy for the major hybrid glycopeptides. Endo-N-acetylglucosaminidase H cleaved the hybrid glycopeptides of Swainsonine-treated BHK cells to produce a [3H]fucose-labelled fragment, presumably Fuca(1->6)GlcNAc-Asn, without affinity for Con ASepharose (Fig. 6) . The rate of hydrolysis of this hybrid glycopeptide fraction by endo-N-acetylglucosaminidase H was similar to that of ovalbumin glycopeptide Man,(GlcNAc)2-Asn and considerably faster than the hydrolysis of the [3H]fucose-labelled hybrid glycopeptide obtained from RicR21 cells (Fig. 6) . The latter glycopeptide contains only three mannose residues in contrast with the five mannose residues present in the hybrid structures from Swainsonine-treated BHK cells. Other work has shown that, compared with Man5(GlcNAc)2Asn, the rate of hydrolysis of Man3(GlcNAc)2-Asn by endo-N-acetylglucosaminidase H is slower by four orders of magnitude (Tarentino & Maley, 1975; Tai et al., 1977 (50 ,ul) were applied and eluted with buffer (5 ml), followed (arrows) by 10 mM-a-methyl glucoside (9 ml) and 500 mM-a-methyl mannoside (9 ml). The fraction size was I ml.
the [3H]fucose-labelled glycopeptide fraction (results not shown), in agreement with the substitution of the Mana(1-->3) residue of the core sequence . Effects of toxic lectins on Swainsonine-treated cells BHK cells grown continuously in the presence of Swainsonine (5 ,ug/ml) were tested for sensitivity to the toxic effects of ricin and modeccin, two galactose-binding lectins, on cellular protein synthesis. As Fig. 7 shows, the trbated cells exhibited a striking increase in ricin resistance, whereas Swainsonine treatment had no protective effect against the cytotoxicity of modeccin (Fig. 7) . The protective effect of Swainsonine against ricin cytotoxicity was readily reversed by removal of the drug from the cells for 1-2 days (Fig. 8) synthesis of hybrid N-glycans containing five mannose residues is fully consistent with the known inhibitory effect of Swainsonine on a-mannosidase II, a Golgilocated enzyme involved in a late stage in glycoprotein processing (Tulsiani et al., 1982 (Tulsiani et al., , 1985 . The structures established for the major hybrid N-glycans are consistent with those proposed for the N-glycans of ax-antitrypsin inhibitor of rat hepatocytes (Gross et al., 1983) , fibronectin (Arumugham & Tanzer, 1983) , viral glycoproteins isolated from infected cells (Elbein et al., 1982; Kang & Elbein, 1983) and human skin fibroblast glycoproteins (Tulsiani & Touster, 1983 ) when these glycoproteins were obtained from cells treated with Swainsonine. A methylation study ofvesicular-stomatitisvirus-G protein produced in Swainsonine-treated BHK cells indicated a structure similar to the sialylated glycopeptide SI-C described here (Kang & Elbein, 1983) . We now show that the major hybrid N-glycan species of glycoproteins obtained from Swainsonine-treated BHK cells carries an a(l-*6)fucose residue in the core sequence and that the sialic acid residues of the acidic hybrid N-glycans are exclusively in a(2->3)-linkage to galactose.
The second major effect of Swainsonine on BHK cells is to induce the intracellular storage of neutral oligosaccharides containing a single N-acetylglucosamine residue and three to five mannose residues. The N-acetylglucosamine residue is present at the reducing terminus of the oligosaccharides and presumably is substituted with the core sequence Mana(--.3)[Mana(16)]-Man,(1_4), since the glycopeptides retain affinity for Con A. Accumulation of these oligosaccharides can be attributed to the effect of Swainsonine, since they were not detected during analysis of the N-glycans of mutant (RicR21) BHK cells. Previous work (Cenci di Bello et al., 1983; Sadeh et al., 1983; Warren et al., 1983) has indicated the presence of neutral oligosaccharides in Swainsonine-treated human fibroblasts that may be structurally similar to those found in our study. The origin of the neutral oligosaccharides found in Swainsonine-treated BHK cells is not known, but could be due to the known inhibition of lysosomal a-mannosidase by Swainsonine and hence incomplete catabolism of cellular glycoproteins. An endo-fl-Nacetylglucosaminidase has been detected in cell extracts that presumably accounts for the cleavage of N-glycans from protein moieties and the exposure of N-acetylglucosamine reducing groups in the neutral oligosaccharides (Overdijk et al., 1981) . Since we find small amounts of neutral oligosaccharides containing three and four mannose residues in Swainsonine-treated cells, some residual a-mannosidase activity must be present in these cells, although concentrations of Swainsonine similar to those used in our study inhibit completely in vitro both a-mannosidase II and lysosomal ax-mannosidase (Dorling et al., 1980; Tulsiani et al., 1985) .
The hybrid N-glycans of RicR21 cells differ from the major hybrid species identified in Swainsonine-treated BHK cells only in the absence of two terminal mannose residues substituted on to the Man(l-÷6) branch of the core sequence. The increased resistance of Swainsonine-treated BHK cells to ricin supports other reports and indicates, in agreement with previous work , that a 3-0-substituted galactose residue binds ricin poorly. Previously, we have shown that ricin-or modeccin-resistant mutants ofBHK cells retain sensitivity to the non-selective lectin (Sargiacomo & Hughes, 1982; in agreement with the present data. Evidently, ricin and modeccin bind to distinctly different carbohydrate sequences and only the ricinbinding receptors are altered in the mutants or during Swainsonine treatment.
